Dr. Maiti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd.
Unit 428
Houston, TX 77030Phone+1 346-725-0901- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2014 - 2017
NRS Medical College CalcuttaClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2022 - 2026
TX State Medical License 2020 - 2026
TN State Medical License 2022 - 2025
WA State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 58 citationsVenetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality.Abhishek Maiti, Wei Qiao, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia
American Journal of Hematology. 2021-03-01 - 145 citationsVenetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid LeukemiaCourtney D. DiNardo, Curtis Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao
Journal of Clinical Oncology. 2021-05-27 - 46 citationsTP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions.Naval G Daver, Abhishek Maiti, Tapan M Kadia, Paresh Vyas, Ravindra Majeti
Cancer Discovery. 2022-11-02
Journal Articles
- Secondary SyphilisPriyanka Bhugra, Abhishek Maiti, The New England Journal of Medicine
Lectures
- Venetoclax (VEN) and tyrosine kinase inhibitor (TKI) combinations in Philadelphia chromosome-positive (Ph+) acute myeloid leukemia (AML) and chronic myeloid leukemia m...2019 ASCO Annual Meeting - 6/1/2019
- Clinical value of event-free survival (EFS) in acute myeloid leukemia (AML).2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
MD Anderson Research Highlights: EHA 2024 Special EditionJune 13th, 2024- Acute Myeloid Leukemia Survivor Shows No Signs of Cancer After Clinical TrialMarch 1st, 2022
- Benjamin S. Abella, MD, MPhil, Named as Chair of the Department of Emergency Medicine for the Mount Sinai Health SystemJune 14th, 2024
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas- Lavaca Medical CenterHallettsville, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
